PharmaResearch Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was KRW 7,517.84 million compared to KRW 5,882 million a year ago. Net income was KRW 40,576.7 million compared to KRW 46,688.66 million a year ago.

Basic earnings per share from continuing operations was KRW 4,067 compared to KRW 4,717 a year ago. Diluted earnings per share from continuing operations was KRW 4,067 compared to KRW 4,715 a year ago. Basic earnings per share was KRW 4,067 compared to KRW 4,717 a year ago.

Diluted earnings per share was KRW 4,135 compared to KRW 4,715 a year ago.